From MedPage Today:

  1. Gabapentin Helps Alcoholics Stay on the Wagon. Patients reporting alcohol dependence were better able to stay sober when treated with oral gabapentin (Neurontin) in a placebo-controlled trial.
  2. Bariatric Surgery Boosts Sexual Health. Obese women who underwent bariatric surgery reported better sexual functioning and quality of life while also experiencing an increase in reproductive hormones.
  3. Diabetes Teams With NPs, PAs ...

    Read more...

From MedPage Today:

  1. New Helmets No Help in Tackling Concussion. Risk and severity of sports-related concussions in high school football players was not affected by make, model, or age of the helmets they use.
  2. Once-Daily LABA Works in COPD. The novel once-daily inhaled bronchodilator olodaterol (proposed trade name Striverdi Respimat) improved lung function and exercise capacity in chronic obstructive pulmonary disease (COPD).

  3. Read more...

From MedPage Today:

  1. FDA Plans to Restrict Vicodin Rx. The FDA wants to tighten the reins on hydrocodone combination drugs such as Vicodin, recommending that they be classified as Schedule II narcotics like OxyContin and fentanyl.
  2. Enrollment in MD, DO Schools Hits New Highs. Medical school applications and enrollment reached record highs this year as organized medicine's cries for more funding for residency slots ...

    Read more...

Recently, I was bemoaning the fact that while the first conference specifically addressing diabetes and depression was a good start, there really wasn’t a significant patient presence. Lots of experienced professionals in the field, but startling few people who had actually walked-the-walk with significant depression for years, decades even. While this format will surely offer a lot of information from the professionals viewpoint, it seems that it would be a bit ...

Read more...

The state of diabetes drugs has gotten to the point where it is good news that a drug does not produce worse outcomes than a placebo. I am not kidding. The New England Journal of Medicine published two trials, each testing whether a diabetes drug increased the risk of heart attacks and death from heart disease. The trials are a result of FDA guidance for companies to assess the cardiovascular safety of new ...

Read more...

From MedPage Today:

  1. Health Prices Still Rising, but Very Slowly. Prices for physician and clinical services continued to climb, but did so at some of the lowest rates in a decade, according to a monthly report from a healthcare research and consulting firm.
  2. Hospital Care Falls Short for Some HF Patients. Hospitalized patients with a secondary diagnosis of heart failure received fewer life saving ...

    Read more...

From MedPage Today:

  1. Sulfonylureas May Raise Death Risk. When taken as first-line therapy, sulfonylureas may increase the risk of death in patients with type 2 diabetes.
  2. Parkinson's Makes for Distrust, Risk-Taking. Compared with healthy controls, patients with Parkinson's disease were markedly less trusting of strangers in a psychosocial experiment, even while showing greater willingness to take risks.
  3. Cholesterol Meds May Hold Glycemic ...

    Read more...

From MedPage Today:

  1. AAFP to Look at Allowing NPs, PAs to Join. The American Academy of Family Physicians wants to further study whether nurse practitioners (NPs) and physician assistants (PAs) should -- or would want to -- become non-voting members.
  2. Insulin Pump Fights Arterial Stiffness. Use of an insulin pump was associated with less arterial stiffness than multiple daily injections in patients with type ...

    Read more...

From MedPage Today:

  1. Type 1 Diabetes Not Controlled in Teens. Glucose control remained inadequate in a cohort of teens with type 1 diabetes, and many of these young patients already had microvascular complications.
  2. White House Seeks to Ease Obamacare Fraud Fears. The White House unveiled several steps this week to protect consumers from fraud in the new online health insurance marketplaces, a move that ...

    Read more...

You probably already know that what you do know about your medicine could kill you. You may not know that what you don't know could do so as well. Hold that somber thought -- we'll get back to it. You, and I, and everyone else has seen those direct-to-patient drug ads that Big Pharma runs on primetime television. Invariably, they feature a person skipping through butterflies and wildflowers, demonstrating the ...

Read more...

Most Popular